P47 How Do HTA Agencies Manage Uncertainties in the Long-Term Clinical Benefit of Gene Therapies? An Analysis of Recent Gene Therapy HTAs in England, Germany, France, Italy, Canada, and the United States
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.062
https://www.valueinhealthjournal.com/article/S1098-3015(23)03191-1/fulltext
Title :
P47 How Do HTA Agencies Manage Uncertainties in the Long-Term Clinical Benefit of Gene Therapies? An Analysis of Recent Gene Therapy HTAs in England, Germany, France, Italy, Canada, and the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03191-1&doi=10.1016/j.jval.2023.09.062
First page :
Section Title :
Open access? :
No
Section Order :
10112